Cita APA (7a ed.)

Hu, X., Fatima, S., Chen, M., Huang, T., Chen, Y. W., Gong, R., . . . Bian, Z. (2021). Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level. Nature Publishing Group.

Cita Chicago Style (17a ed.)

Hu, Xianjing, et al. Dihydroartemisinin Is Potential Therapeutics for Treating Late-stage CRC by Targeting the Elevated C-Myc Level. Nature Publishing Group, 2021.

Cita MLA (8a ed.)

Hu, Xianjing, et al. Dihydroartemisinin Is Potential Therapeutics for Treating Late-stage CRC by Targeting the Elevated C-Myc Level. Nature Publishing Group, 2021.